We provide evidence that the cannabidiol aminoquinone VCE-004.8 is a selective partial PPARγ agonist lacking adipogenic activity that alleviates metabolic perturbations and inflammatory parameters associated to obesity. This evidence concerns the gene PPARG and obesity due to melanocortin 4 receptor deficiency.